PhaseBio Pharmaceuticals Inc (NASDAQ:PHAS)

3.86
Delayed Data
As of Dec 12
 +0.59 / +18.04%
Today’s Change
2.56
Today|||52-Week Range
16.65
+24.92%
Year-to-Date
No recent news for PhaseBio Pharmaceuticals Inc.

Today’s Trading

Previous close3.27
Today’s open3.28
Day’s range3.24 - 3.89
Volume547,360
Average volume (3 months)306,019
Market cap$96.1M
Data as of 3:59pm ET, 12/12/2019

Growth & Valuation

Earnings growth (last year)-1,004.69%
Earnings growth (this year)+68.77%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.61

Competitors

 Today’s
change
Today’s
% change
ADROAduro Biotech Inc+0.01+0.85%
MRNSMarinus Pharmaceutic...-0.07-3.93%
SBBPStrongbridge Biophar...+0.04+2.23%
ORMPOramed Pharmaceutica...+0.14+2.70%
Data as of 4:00pm ET, 12/12/2019

Financials

Next reporting dateMarch 31, 2020
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$0.00
Annual profit (last year)-$23.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Malvern, Pennsylvania

Forecasts